Invesco’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-169,052
| Closed | -$20.5M | – | 4005 |
|
|
2023
Q1 | $20.5M | Hold |
169,052
| – | – | 0.01% | 1338 |
|
|
2022
Q4 | $19.4M | Hold |
169,052
| – | – | 0.01% | 1390 |
|
|
2022
Q3 | $17.1M | Buy |
169,052
+20,000
| +13% | +$2.02M | 0.01% | 1421 |
|
|
2022
Q2 | $15.1M | Buy |
149,052
+27,000
| +22% | +$2.74M | ﹤0.01% | 1546 |
|
|
2022
Q1 | $14.2M | Hold |
122,052
| – | – | ﹤0.01% | 1730 |
|
|
2021
Q4 | $14M | Buy |
+122,052
| New | +$14M | ﹤0.01% | 1786 |
|
|
2020
Q4 | – | Sell |
-156,700
| Closed | -$17.5M | – | 3807 |
|
|
2020
Q3 | $17.5M | Buy |
156,700
+23,000
| +17% | +$2.57M | 0.01% | 1372 |
|
|
2020
Q2 | $14M | Buy |
+133,700
| New | +$14M | 0.01% | 1453 |
|